Nyxoah SA (NYXH)
|Net Income (ttm)||-18.91M|
|Day's Range||30.67 - 32.95|
|52-Week Range||0.00 - 32.95|
|Price Target||41.49 (+38.3%)|
|Est. Earnings Date||Nov 30, 2021|
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric, minimally invasive, next generation hypoglossal neurostimulation therapy for the treatment of moderate to severe OSA. Our innovative technology platform is a first-of-its-kind bilateral hypoglossal nerve stimulation device designed to treat OSA, by maintaining an open airway for a restful night’s sleep. We started generatin... [Read more...]
Financial PerformanceFinancial numbers in millions EURFinancial Statements
The FDA has granted Breakthrough Device Designation to Nyxoah SA (NASDAQ: NYXH) Genio bilateral hypoglossal nerve stimulation system. The system treats adult patients with moderate to severe Obstructive...
Nyxoah Announc es Participation in the Cantor 2021 Virtual Global Healthcare Conference
Nyxoah (NYXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors
Nyxoah to Release First Half 2021 Financial Results on August 31 and Host Earnings Conference Call on September 1, 2021
Mont-Saint-Guibert, Belgium. - August 11, 2021, 10:30 pm CET / 4:30 pm ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the developmen...
PRESS RELEASE REGULATED INFO R MATION
Nyxoah Announces Closing of Nasdaq Initial Public Offering and Underwriters' Full Exercise of Option to Purchase Addi...
REGULATED INFORMATION INSIDE INFORMATION
Mont-Saint-Guibert, Belgium – July 2, 2021, 2:40pm CET / 8:40am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and c...
REGULATED INFORMATION - INSIDE INFORMATION Nyxoah Announces Launch of Proposed Public Offering in the United States...
Nyxoah SA has filed to go public with an IPO on the NASDAQ.